ArticleExperimental and therapeutic medicine2018

Prolyl oligopeptidase inhibitor suppresses the upregulation of ACSDKP in patients with acute myeloid leukemia.

Haiwu Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.